New York, NYNCT04550377Now EnrollingIRB Ready

Post Traumatic Stress Disorder Clinical Trial in New York, NY

Access cutting-edge post traumatic stress disorder treatment through this phase 2 clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by NYU Langone Health

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access post traumatic stress disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related post traumatic stress disorder treatment provided free

Apply for This New York Location

Check if you qualify for this post traumatic stress disorder clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Post Traumatic Stress Disorder Study in New York

This will be a randomized placebo controlled study to test the efficacy of cannabidiol (CBD) as a treatment for symptoms of post-traumatic stress disorder (PTSD). Subjects, 120 in total, will be males and females with PTSD, half of which will have comorbid mild traumatic brain injury (TBI). There will be three study arms, each with 40 subjects: 1) Oral CBD 400 mg daily; 2) Oral CBD 800 mg daily, and 3) Placebo daily. Treatment duration will be 8 weeks. The primary outcome will be change in PTSD symptoms as measured by change in the Clinician-Administered PTSD Scale (CAPS-5) total score.

Sponsor: NYU Langone Health

Who Can Participate

Inclusion Criteria

Meets clinical criteria for Posttraumatic Stress Disorder (PTSD) as per Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
TBI present (for PTSD+TBI subjects only) as per American Congress of Rehabilitation Medicine (ACRM) definition
Mild TBI (for PTSD+TBI subjects only) as per Ohio State University Identification Screener
Able to provide at least 2 locators
Able to provide informed consent
Confirmation that the participant is reliably domiciled
Agreement to abstain from all other cannabinoid use for the duration of the study
Willingness to use contraception if of childbearing potential.

Exclusion Criteria

History of open head injury
TBI within the last 6 months
Moderate or Severe TBI
SUD in the last 12 months other than mild AUD or nicotine use
Use of any cannabinoid containing product within the last 1 month
Positive urine drug screen (Positive for cannabinoids, amphetamine, cocaine, opioids)
Currently prescribed medications with possible CBD-drug interactions
Lifetime history of any psychiatric disorder with psychotic features, bipolar disorder
Exposure to trauma in the last 30 days, including police duty or military service
Psychotherapy for PTSD or other psychiatric conditions initiated within 2 months of screening
Not stable for at least 2 months on psychiatric medication, anticonvulsants, antihypertensive medication, sympathomimetic medication, estrogen replacement therapy, medications associated with neurogenesis, or steroid medication
Active suicide attempt within the past year
Current significant suicidality (assessed using the C-SSRS), any significant suicidal behavior in the past 12 months, or any history of serious suicide attempts requiring hospitalization, or current significant homicidality.
Neurologic disorder or systemic illness affecting CNS function (apart from TBI)
Major medical illness (i.e. cancer or infectious disease.)
Clinical diagnosis of anemia, advised by physician to avoid blood draws
Significant laboratory abnormalities, significantly impaired hepatic function, abnormalities in complete blood count or metabolic panel
Significant allergic reactions to the drug including cannabinoids or sesame oil
Pregnancy or lactation
Contraindication to MRI
Males and females who plan to conceive a child during or two weeks following the study
Active legal problems likely to result in incarceration within 12 weeks of treatment initiation
Has a high risk of adverse emotional or behavioral reaction (e.g., evidence of serious personality disorder, antisocial behavior, serious current stressors, and lack of meaningful social support).
Inpatient psychiatric treatment in past 12 months, with the exception of detox and extended ED stays.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT04550377) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Post Traumatic Stress Disorder Treatment Options in New York, NY

If you're searching for post traumatic stress disorder treatment options in New York, NY, this clinical trial (NCT04550377) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced post traumatic stress disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all post traumatic stress disorder clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in New York, NY

See all rheumatoid arthritis clinical trials recruiting in New York — not just this study.

Browse Rheumatoid Arthritis Trials in New York →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY